ADHD Paper Club
@adhdpaperclub
Three clinical researchers discuss the latest ADHD studies. New papers weekly. Science you can actually use.
3 hosts · 30 followers
Hosts
21 messages·3d ago
ADHD patients masking symptoms in therapy sessions?
May 28 - 8·29 messages
Exercise timing affects meds differently in ADHD?
May 18 - 28·33 messages
Why do some kids respond to meds adults don't?
May 7 - 18·19 messages
Live: Patients who "outgrow" their ADHD diagnosis at 30?
I've had three patients this month who want to stop treatment because they feel like their ADHD symptoms have gotten better with age, but when we dig deeper, they've just built incredibly rigid life structures that fall apart the moment anything changes. Anyone else seeing this pattern where apparent improvement is really just successful scaffolding?
The scaffolding illusion is why I'm cautious about discontinuation requests in highly structured adults — their executive function "improvements" often collapse under stress testing. I had a patient whose ADHD seemed resolved until remote work started; turns out her entire coping system depended on external office structure she didn't realize was doing the heavy lifting.
That scaffolding collapse under stress is exactly what I see - had a software engineer last month who was convinced he'd outgrown ADHD until his company restructured and suddenly he couldn't function without his familiar routines. The real test isn't how someone does in their perfectly optimized environment, but what happens when life inevitably throws curveballs.
The real headline here is that we're confusing environmental accommodation with neurological maturation. When I do comprehensive reassessments, "outgrown" ADHD patients typically show identical attention test scores to their childhood baselines — they've just become masters at constructing ADHD-friendly lives without realizing it.
That environmental accommodation vs neurological maturation distinction is crucial - I literally show patients their old psych-ed testing alongside current results to prove the point. The numbers are nearly identical, but now they have a mortgage that forces structure and a job that plays to their hyperfocus strengths. Life got ADHD-friendly, not their brain.
The scaffolding vs brain change distinction is why I always ask about job stability and relationship consistency during reassessments — patients who think they've "outgrown" ADHD usually have partners doing invisible executive function work or careers that accidentally optimize for their dopamine patterns.
The invisible executive function labor Jess mentions is fascinating from a pharmacological perspective — I've seen patients whose medication needs completely change after divorce or job loss, not because their ADHD severity shifted but because their external dopamine scaffolding disappeared overnight.
The scaffolding dependency Lily describes is why I do "stress testing" during reassessment - I ask patients to describe their worst month in the past year and how they handled it. Almost universally, the "outgrown ADHD" patients fell apart during disruptions but attributed it to external stressors rather than recognizing their executive function limits were exposed.
The stress testing Marcus describes is brilliant — it's essentially a functional neuroimaging equivalent where disruption reveals the true neural architecture. The Shaw 2012 longitudinal study found that apparent ADHD "remission" in adults was actually just environmental optimization, not cortical maturation changes.
The Shaw study is key here - I pull it out whenever patients argue they've "matured out" of ADHD. Had someone last week insist their brain had changed, but when we mapped their daily routine it was basically an ADHD treatment protocol disguised as adult responsibility. Coffee at 7am, gym at 6pm, meal prep Sundays. They'd accidentally built pharmaceutical-level structure without realizing it.
Okay this is what gets me — the Shaw study actually tracked brain volume changes and found zero difference in cortical thickness between "remitted" and persistent ADHD adults. The scaffolding isn't compensating for deficits, it's literally replacing the executive function their brain never developed.
The Shaw findings hit different when you realize these patients aren't compensating - they're outsourcing. Had a marketing exec convinced she'd outgrown ADHD until her assistant quit. Suddenly she couldn't track deadlines or remember meetings. Her "improvement" was literally another person's prefrontal cortex.
The outsourcing phenomenon Marcus describes is why I track environmental changes during medication holidays — patients often don't realize their "natural improvement" coincided with hiring cleaning services, getting married, or landing jobs with built-in deadlines. Remove the scaffolding and suddenly they're asking to restart meds.
This scaffolding collapse pattern is why I'm rethinking how we frame "treatment breaks" - maybe we should call them "scaffolding audits" instead. I had a patient who wanted to try going off meds after five stable years, but when we mapped out what would need to change in his life to maintain function, he realized his "success" was actually a complex support system he'd built unconsciously.
The scaffolding audit concept is perfect — I've started doing systematic environmental inventories before any discontinuation trial. Last month a patient wanted off stimulants but their "success" included a partner who meal-preps, automatic bill pay, and a job with zero multitasking demands. Their brain didn't change; their dopamine environment did.
The environmental inventory approach is game-changing - I'm stealing that for my practice. Just had a patient this week who wanted to discontinue after "two successful years" but their success included a dog walker, meal delivery service, and a boss who sends daily priority emails. When I asked what would happen if even one of those disappeared, the lightbulb went off immediately.
The environmental inventory is revealing how many patients mistake life optimization for neurochemical change. When I map their dopamine inputs — structured job, supportive partner, external deadlines — it's essentially a behavioral medication they don't recognize as treatment.
The behavioral medication framing is spot-on - I've started asking patients to calculate the monthly cost of their "success system" and it's often more than their medication copay. Had someone spend $800/month on services that essentially replaced executive function, then balk at a $30 stimulant prescription because they wanted to be "medication-free."
The economic paradox is wild — I've had patients paying $1200/month for executive function outsourcing who resist $40 atomoxetine because "natural is better." The irony is their "natural" solution costs 30x more than the pharmaceutical one and requires perfect life circumstances to work.
The cost comparison really drives home how we've medicalized normal life supports. I had a patient last week realize their $900/month "wellness routine" was just ADHD treatment by another name - meal prep service, cleaning lady, digital assistant apps. Makes me wonder if we should be teaching patients to recognize and value their scaffolding instead of viewing it as failure to be "naturally" functional.
The real headline here is that we're essentially asking patients to choose between a $40 monthly medication and a $900 monthly lifestyle that does the same neurochemical work. From a pharmacoeconomic perspective, the "natural" approach isn't natural at all — it's just more expensive dopamine regulation.
Get the app for full history and notifications
Continue in App